SCHEMBL6795776

SCHEMBL6795776

O=C(c1ncc[nH]1)c1cccc2nc3ccccc3nc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.58
ALDH1A1 P00352 2/20 0.54
HTT P42858 3/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
GLA P06280 1/20 0.45
RAB9A P51151 4/20 0.43
NPC1 O15118 2/20 0.43
MAPT P10636 4/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 2/20 0.43
F2RL1 P55085 1/20 0.42
NPSR1 Q6W5P4 2/20 0.40
GAA P10253 1/20 0.40
CSNK1A1 P48729 1/20 0.38
TYRO3 Q06418 1/20 0.38
DYRK1B Q9Y463 1/20 0.38
THRB P10828 1/20 0.38
MEN1 O00255 1/20 0.38
CYP3A4 P08684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27805818 0.81 KMT2A (0.77) KMT2AALDH1A1HTTSMN1; SMN2GLA
SCHEMBL3535267 0.81 KMT2A (0.56) KMT2AALDH1A1HTTSMN1; SMN2GLA
SCHEMBL28382224 0.79 ALDH1A1 (0.75) KMT2AALDH1A1HTTSMN1; SMN2RAB9A
SCHEMBL7193170 0.78 KMT2A (0.63) KMT2AHTTSMN1; SMN2GLARAB9A
SCHEMBL2450877 0.75 KMT2A (0.69) KMT2AALDH1A1HTTSMN1; SMN2GLA
SCHEMBL3536797 0.75 KMT2A (0.51) KMT2AHTTSMN1; SMN2GLARAB9A
SCHEMBL653632 0.74 KMT2A (0.67) KMT2AALDH1A1HTTSMN1; SMN2GLA
SCHEMBL395690 0.74 KMT2A (0.67) KMT2AALDH1A1HTTSMN1; SMN2GLA
SCHEMBL28358852 0.74 KMT2A (0.67) KMT2AALDH1A1HTTSMN1; SMN2GLA
SCHEMBL3462830 0.74 KMT2A (0.67) KMT2AALDH1A1HTTSMN1; SMN2GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004026846-A1 DNA-TARGETED BENZOTRIAZINE 1,4-DIOXIDES AND THEIR USE IN CANCER THERAPY AUCKLAND UNISERVICES LIMITED (NZ) 2004-04-01 WO disclosed